Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes
Tóm tắt
Next-generation DNA sequencing is opening new avenues for genetic association studies in common diseases that, like deep vein thrombosis (DVT), have a strong genetic predisposition still largely unexplained by currently identified risk variants. In order to develop sequencing and analytical pipelines for the application of next-generation sequencing to complex diseases, we conducted a pilot study sequencing the coding area of 186 hemostatic/proinflammatory genes in 10 Italian cases of idiopathic DVT and 12 healthy controls. A molecular-barcoding strategy was used to multiplex DNA target capture and sequencing, while retaining individual sequence information. Genomic libraries with barcode sequence-tags were pooled (in pools of 8 or 16 samples) and enriched for target DNA sequences. Sequencing was performed on ABI SOLiD-4 platforms. We produced > 12 gigabases of raw sequence data to sequence at high coverage (average: 42X) the 700-kilobase target area in 22 individuals. A total of 1876 high-quality genetic variants were identified (1778 single nucleotide substitutions and 98 insertions/deletions). Annotation on databases of genetic variation and human disease mutations revealed several novel, potentially deleterious mutations. We tested 576 common variants in a case-control association analysis, carrying the top-5 associations over to replication in up to 719 DVT cases and 719 controls. We also conducted an analysis of the burden of nonsynonymous variants in coagulation factor and anticoagulant genes. We found an excess of rare missense mutations in anticoagulant genes in DVT cases compared to controls and an association for a missense polymorphism of FGA (rs6050; p = 1.9 × 10-5, OR 1.45; 95% CI, 1.22-1.72; after replication in > 1400 individuals). We implemented a barcode-based strategy to efficiently multiplex sequencing of hundreds of candidate genes in several individuals. In the relatively small dataset of our pilot study we were able to identify bona fide associations with DVT. Our study illustrates the potential of next-generation sequencing for the discovery of genetic variation predisposing to complex diseases.
Tài liệu tham khảo
Tapson VF: Acute pulmonary embolism. N Engl J Med. 2008, 358: 1037-52. 10.1056/NEJMra072753.
Sørensen HT, Riis AH, Diaz LJ, Andersen EW, Baron JA, Andersen PK: Familial risk of venous thromboembolism: a nationwide cohort study. J Thromb Haemost. 2011, 9: 320-4. 10.1111/j.1538-7836.2010.04129.x.
Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J: Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet. 2000, 67: 1452-9.
Heit JA, Phelps MA, Ward SA, Slusser JP, Petterson TM, De Andrade M: Familial segregation of venous thromboembolism. J Thromb Haemost. 2004, 2: 731-6. 10.1111/j.1538-7933.2004.00660.x.
Larsen TB, Sørensen HT, Skytthe A, Johnsen SP, Vaupel JW, Christensen K: Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology. 2003, 14: 328-32.
Dahlbäck B: Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008, 112: 19-27. 10.1182/blood-2008-01-077909.
Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, Catanese J, Young BA, Reitsma PH, Devlin JJ, Rosendaal FR: Gene variants associated with deep vein thrombosis. JAMA. 2008, 299: 1306-14. 10.1001/jama.299.11.1306.
Trégouët DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Juhan-Vague I, Alessi MC, Tiret L, Lathrop M, Emmerich J, Morange PE: Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood. 2009, 113: 5298-303. 10.1182/blood-2008-11-190389.
Morange PE, Bezemer I, Saut N, Bare L, Burgos G, Brocheton J, Durand H, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Germain M, Nicaud V, Heath S, Ninio E, Delluc A, Münzel T, Zeller T, Brand-Herrmann SM, Alessi MC, Tiret L, Lathrop M, Cambien F, Blankenberg S, Emmerich J, Trégouët DA, Rosendaal FR: A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. Am J Hum Genet. 2010, 86: 592-5. 10.1016/j.ajhg.2010.02.011.
Morange PE, Tregouet DA: Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?. Br J Haematol. 2010, 148: 495-506. 10.1111/j.1365-2141.2009.07975.x.
Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, Shaffer T, Wong M, Bhattacharjee A, Eichler EE, Bamshad M, Nickerson DA, Shendure J: Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009, 461: 272-6. 10.1038/nature08250.
Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, Shendure J, Bamshad MJ: Exome sequencing identifies the cause of a mendelian disorder. Nat Genet. 2010, 42: 30-5. 10.1038/ng.499.
Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L, Bainbridge M, Dinh H, Jing C, Wheeler DA, McGuire AL, Zhang F, Stankiewicz P, Halperin JJ, Yang C, Gehman C, Guo D, Irikat RK, Tom W, Fantin NJ, Muzny DM, Gibbs RA: Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med. 2010, 362: 1181-91. 10.1056/NEJMoa0908094.
Frezzato M, Tosetto A, Rodeghiero F: Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol. 1996, 143: 1257-65.
[http://www.appliedbiosystems.com/absite/us/en/home/applications-technologies/solid-next-generation-sequencing/next-generation-systems/solid-sequencing-chemistry.html]
Homer N, Merriman B, Nelson SF: BFAST: An alignment tool for large scale genome resequencing. PLoS ONE. 2009, 4: e7767-10.1371/journal.pone.0007767.
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup: The Sequence alignment/map (SAM) format and SAMtools. Bioinformatics. 2009, 25: 2078-9. 10.1093/bioinformatics/btp352.
1000 Genomes Project Consortium, Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA: A map of human genome variation from population-scale sequencing. Nature. 2010, 467: 1061-73. 10.1038/nature09534.
Wang K, Li M, Hakonarson H: ANNOVAR: Functional annotation of genetic variants from next-generation sequencing data. Nucleic Acids Research. 2010, 38: e164-10.1093/nar/gkq603.
Ng PC, Henikoff S: Accounting for human polymorphisms predicted to affect protein function. Genome Res. 2002, 12: 436-46. 10.1101/gr.212802.
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods. 2010, 7: 248-249. 10.1038/nmeth0410-248.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007, 81: 559-75. 10.1086/519795.
Zhang J, Wheeler DA, Yakub I, Wei S, Sood R, Rowe W, Liu PP, Gibbs RA, Buetow KH: SNPdetector: a software tool for sensitive and accurate SNP detection. PLoS Comput Biol. 2005, 1: e53-10.1371/journal.pcbi.0010053.
Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, Cooper DN: The Human Gene Mutation Database: 2008 update. Genome Med. 2009, 1: 13-10.1186/gm13.
Ko YL, Hsu LA, Hsu TS, Tsai CT, Teng MS, Wu S, Chang CJ, Lee YS: Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population. Hum Genet. 2006, 119: 84-91. 10.1007/s00439-005-0102-0.
Vaidya D, Yanek LR, Herrera-Galeano JE, Mathias RA, Moy TF, Faraday N, Becker LC, Becker DM: A common variant in the Von Willebrand factor gene is associated with multiple functional consequences. Am J Hematol. 2010, 85: 971-3. 10.1002/ajh.21859.
Smith NL, Rice KM, Bovill EG, Cushman M, Bis JC, McKnight B, Lumley T, Glazer NL, van Hylckama Vlieg A, Tang W, Dehghan A, Strachan DP, O'Donnell CJ, Rotter JI, Heckbert SR, Psaty BM, Rosendaal FR: Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Blood. 2011, 117: 6007-11. 10.1182/blood-2010-10-315473.
Momozawa Y, Mni M, Nakamura K, Coppieters W, Almer S, Amininejad L, Cleynen I, Colombel JF, de Rijk P, Dewit O, Finkel Y, Gassull MA, Goossens D, Laukens D, Lémann M, Libioulle C, O'Morain C, Reenaers C, Rutgeerts P, Tysk C, Zelenika D, Lathrop M, Del-Favero J, Hugot JP, de Vos M, Franchimont D, Vermeire S, Louis E, Georges M: Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet. 2011, 43: 43-7. 10.1038/ng.733.
Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J, Scherer S, Scheetz TE, Smith RJ: Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA. 2010, 107: 21104-9. 10.1073/pnas.1012989107.
Fechtel K, Osterbur ML, Kehrer-Sawatzki H, Stenson PD, Cooper DN: Delineating the Hemostaseome as an aid to individualize the analysis of the hereditary basis of thrombotic and bleeding disorders. Hum Genet. 2011, 130: 149-66. 10.1007/s00439-011-0984-y.
Dewey FE, Chen R, Cordero SP, Ormond KE, Caleshu C, Karczewski KJ, Whirl-Carrillo M, Wheeler MT, Dudley JT, Byrnes JK, Cornejo OE, Knowles JW, Woon M, Sangkuhl K, Gong L, Thorn CF, Hebert JM, Capriotti E, David SP, Pavlovic A, West A, Thakuria JV, Ball MP, Zaranek AW, Rehm HL, Church GM, West JS, Bustamante CD, Snyder M, Altman RB, Klein TE, Butte AJ, Ashley EA: Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet. 2011, 7: e1002280-10.1371/journal.pgen.1002280.
Carter AM, Catto AJ, Kohler HP, Ariëns RA, Stickland MH, Grant PJ: alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood. 2000, 96 (3): 1177-9. Aug 1
Rasmussen-Torvik LJ, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Rosamond WD, Folsom AR: The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thromb Res. 2007, 121: 1-7. 10.1016/j.thromres.2007.02.008.
Arellano AR, Bezemer ID, Tong CH, Catanese JJ, Devlin JJ, Reitsma PH, Bare LA, Rosendaal FR: Gene variants associated with venous thrombosis: confirmation in the MEGA study. J Thromb Haemost. 2010, 8: 1132-4.
Standeven KF, Grant PJ, Carter AM, Scheiner T, Weisel JW, Ariëns RA: Functional analysis of the fibrinogen alpha Thr312Ala polymorphism: effects on fibrin structure and function. Circulation. 2003, 107: 2326-30. 10.1161/01.CIR.0000066690.89407.CE.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1755-8794/5/7/prepub